112 related articles for article (PubMed ID: 3320097)
1. Circulating micromegakaryocytes in myelodysplasia.
Erber WN; Jacobs A; Oscier DG; O'Hea AM; Mason DY
J Clin Pathol; 1987 Nov; 40(11):1349-52. PubMed ID: 3320097
[TBL] [Abstract][Full Text] [Related]
2. Detection of cells of megakaryocyte lineage in haematological malignancies by immuno-alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies.
Erber WN; Breton-Gorius J; Villeval JL; Oscier DG; Bai Y; Mason DY
Br J Haematol; 1987 Jan; 65(1):87-94. PubMed ID: 3545280
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
Thiele J; Hoffmann I; Bertsch HP; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
[TBL] [Abstract][Full Text] [Related]
5. Immunotyping of blasts in refractory anaemia with excess of blasts.
Oertel J; Kleiner S; Huhn D
Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147
[TBL] [Abstract][Full Text] [Related]
6. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
[TBL] [Abstract][Full Text] [Related]
7. CD 34 immunotyping of blasts in myelodysplasia.
Oertel J; Oertel B; Beyer J; Huhn D
Ann Hematol; 1994 Feb; 68(2):77-80. PubMed ID: 7511934
[TBL] [Abstract][Full Text] [Related]
8. [Serum proteomics in patients with RAEB myelodysplastic syndromes].
Zhong LY; Liu TH; Li YQ; Geng SX; Lu ZS; Weng JY; Wu SJ; Luo CW; Du X
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1799-801. PubMed ID: 19778794
[TBL] [Abstract][Full Text] [Related]
9. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
11. A case of myelodysplastic syndrome with abnormal megakaryocytes and ins(8;3)(q24;q21q26).
Bachy-Delhomme M; Bertheas MF; Jaubert J; Calmard P; Vasselon C; Reynaud J; Brizard CP
Cancer Genet Cytogenet; 1991 Aug; 55(1):31-4. PubMed ID: 1913604
[TBL] [Abstract][Full Text] [Related]
12. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
13. Megakaryocytic ploidy in myelodysplastic syndromes.
Kobayashi Y; Ozawa M; Maruo N; Kondo M
Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical detection of normal and abnormal megakaryocytes using monoclonal antibody to glycoprotein IIb-IIIa (TP80): the quantitative assay in normal and in leukaemic patients.
Sato T; Shichishima T; Kimura H; Uchida T; Kariyone S; Ohto H; Maeda H
Scand J Haematol; 1986 May; 36(5):415-23. PubMed ID: 2943015
[TBL] [Abstract][Full Text] [Related]
15. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
16. [Emperipolesis by megakaryocytes in RAEB in T (refractory anemia with excess of blasts in transformation)].
Natori H; Natori K; Naito K; Nakamura E; Tanaka K; Egami K; Honda J; Imamura Y; Osabe S; Yasuda K
Rinsho Ketsueki; 1988 Sep; 29(9):1504-10. PubMed ID: 3216522
[No Abstract] [Full Text] [Related]
17. Familial myelodysplasia: progressive disease associated with emergency of monosomy 7.
Paul B; Reid MM; Davison EV; Abela M; Hamilton PJ
Br J Haematol; 1987 Mar; 65(3):321-3. PubMed ID: 3567084
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
